In the last trading session, 1.55 million Enveric Biosciences Inc (NASDAQ:ENVB) shares changed hands as the company’s beta touched 0.56. With the company’s per share price at $2.09 changed hands at -$1.81 or -46.41% during last session, the market valuation stood at $0.10M. ENVB’s last price was a discount, traded about -1995.69% off its 52-week high of $43.80. The share price had its 52-week low at $3.88, which suggests the last value was -85.65% down since then. When we look at Enveric Biosciences Inc’s average trading volume, we note the 10-day average is 0.34 million shares, with the 3-month average coming to 63.66K.
Enveric Biosciences Inc (NASDAQ:ENVB) trade information
Instantly ENVB was in red as seen at the end of in last trading. With action -55.56%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -61.12%, with the 5-day performance at -55.56% in the red. However, in the 30-day time frame, Enveric Biosciences Inc (NASDAQ:ENVB) is -57.31% down. Looking at the short shares, we see there were 0.33 million shares sold at short interest cover period of 0.31 days.
Enveric Biosciences Inc (ENVB) estimates and forecasts
Data shows that the Enveric Biosciences Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -70.35% over the past 6 months, a 74.04% in annual growth rate that is considerably higher than the industry average of 15.90%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 71.22%.
ENVB Dividends
Enveric Biosciences Inc is expected to release its next quarterly earnings report in March.
Enveric Biosciences Inc (NASDAQ:ENVB)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 6.93% of Enveric Biosciences Inc shares while 7.06% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 7.58%. There are 7.06% institutions holding the Enveric Biosciences Inc stock share, with ADVISORSHARES INVESTMENTS LLC the top institutional holder. As of 2024-06-30, the company held 7.9233% of the shares, roughly 0.32 million ENVB shares worth $0.19 million.
GEODE CAPITAL MANAGEMENT, LLC holds the second largest percentage of outstanding shares, with 1.1161% or 44659.0 shares worth $27688.0 as of 2024-06-30.
Among Mutual Funds, the top two as of Nov 30, 2024 were AdvisorShares Trust-AdvisorShares Psychedelics ETF and Fidelity NASDAQ Composite Index Fund . With 39.99 shares estimated at $83579.0 under it, the former controlled 0.39% of total outstanding shares. On the other hand, Fidelity NASDAQ Composite Index Fund held about 0.11% of the shares, roughly 10.91 shares worth around $22806.0.
